Yongxing Gong
Tianjin University(CN)China North Industries Group Corporation (China)(CN)
Publications by Year
Research Areas
Renal and related cancers, PI3K/AKT/mTOR signaling in cancer, Renal cell carcinoma treatment, Ovarian cancer diagnosis and treatment, Thyroid Cancer Diagnosis and Treatment
Most-Cited Works
- → The mutational landscape of adenoid cystic carcinoma(2013)455 cited
- → Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation(2013)359 cited
- → An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors(2009)232 cited
- → Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins(2014)173 cited
- → Targeting therapeutic vulnerabilities with PARP inhibition and radiation in IDH-mutant gliomas and cholangiocarcinomas(2020)105 cited
- → Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers(2011)103 cited
- → Global transcriptional analysis of acid-inducible genes in Streptococcus mutans: multiple two-component systems involved in acid adaptation(2009)66 cited
- → Pan-Cancer Analysis Links PARK2 to BCL-XL-Dependent Control of Apoptosis(2016)31 cited
- → Mitonuclear genotype remodels the metabolic and microenvironmental landscape of Hürthle cell carcinoma(2022)20 cited
- → Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity(2021)11 cited